Pacific Biosciences Of California Shares Outstanding 2010-2023 | PACB

Pacific Biosciences Of California shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Pacific Biosciences Of California Annual Shares Outstanding
(Millions of Shares)
2023 254
2022 225
2021 204
2020 175
2019 153
2018 135
2017 106
2016 89
2015 76
2014 70
2013 63
2012 56
2011 54
2010 10
2009 1
Pacific Biosciences Of California Quarterly Shares Outstanding
(Millions of Shares)
2023-12-31 254
2023-09-30 255
2023-06-30 250
2023-03-31 242
2022-12-31 225
2022-09-30 225
2022-06-30 224
2022-03-31 222
2021-12-31 204
2021-09-30 215
2021-06-30 199
2021-03-31 195
2020-12-31 175
2020-09-30 167
2020-06-30 154
2020-03-31 156
2019-12-31 153
2019-09-30 153
2019-06-30 153
2019-03-31 151
2018-12-31 135
2018-09-30 135
2018-06-30 132
2018-03-31 124
2017-12-31 106
2017-09-30 116
2017-06-30 97
2017-03-31 93
2016-12-31 89
2016-09-30 92
2016-06-30 88
2016-03-31 84
2015-12-31 76
2015-09-30 80
2015-06-30 75
2015-03-31 74
2014-12-31 70
2014-09-30 71
2014-06-30 71
2014-03-31 68
2013-12-31 63
2013-09-30 66
2013-06-30 62
2013-03-31 57
2012-12-31 56
2012-09-30 56
2012-06-30 56
2012-03-31 55
2011-12-31 54
2011-09-30 54
2011-06-30 53
2011-03-31 53
2010-12-31 10
2010-09-30 1
2010-06-30 1
2010-03-31 1
2009-12-31
2009-09-30 1
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.550B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.236B 27.53
Intuitive Surgical (ISRG) United States $141.461B 85.22
Edwards Lifesciences (EW) United States $53.716B 34.96
DexCom (DXCM) United States $52.240B 79.13
IDEXX Laboratories (IDXX) United States $44.882B 52.61
Alcon (ALC) Switzerland $43.802B 31.39
IQVIA Holdings (IQV) United States $42.121B 24.44
STERIS (STE) Ireland $22.993B 26.87
Waters (WAT) United States $21.115B 31.03
SONOVA HOLDING (SONVY) Switzerland $19.146B 0.00
Hologic (HOLX) United States $17.508B 19.59
Fresenius Medical Care AG KGaA (FMS) Germany $12.893B 15.05
ShockWave Medical (SWAV) United States $12.394B 77.13
Sysmex ADR (SSMXY) Japan $11.077B 34.74
Teleflex (TFX) United States $10.252B 15.96
Globus Medical (GMED) United States $8.718B 25.56
Penumbra (PEN) United States $7.890B 89.66
Masimo (MASI) United States $6.588B 37.95
Glaukos (GKOS) United States $5.530B 0.00
TransMedics (TMDX) United States $4.545B 431.19
Integer Holdings (ITGR) United States $4.051B 24.48
PROCEPT BioRobotics (PRCT) United States $3.502B 0.00
LivaNova (LIVN) United Kingdom $3.355B 19.92
Tandem Diabetes Care (TNDM) United States $3.055B 0.00
Elekta AB (EKTAY) Sweden $2.926B 20.07
Inari Medical (NARI) United States $2.660B 0.00
Nihon Kohden (NHNKY) Japan $2.485B 21.02
RxSight (RXST) United States $2.243B 0.00
Integra LifeSciences Holdings (IART) United States $2.170B 9.46
Veracyte (VCYT) United States $1.749B 0.00
Alphatec Holdings (ATEC) United States $1.546B 0.00
Artivion (AORT) United States $0.978B 93.84
AVANOS MEDICAL, INC (AVNS) United States $0.936B 18.21
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.875B 0.00
OrthoPediatrics (KIDS) United States $0.763B 0.00
Mesa Laboratories (MLAB) United States $0.659B 22.38
Paragon 28 (FNA) United States $0.635B 0.00
SiBone (SIBN) United States $0.615B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.563B 0.00
IRadimed (IRMD) United States $0.532B 29.81
Pulse Biosciences (PLSE) United States $0.431B 0.00
Nevro (NVRO) United States $0.419B 0.00
Tactile Systems Technology (TCMD) United States $0.326B 11.16
Treace Medical Concepts (TMCI) United States $0.310B 0.00
Sight Sciences (SGHT) United States $0.266B 0.00
AxoGen (AXGN) United States $0.264B 0.00
EDAP TMS S.A (EDAP) France $0.249B 0.00
AngioDynamics (ANGO) United States $0.242B 0.00
908 Devices (MASS) United States $0.236B 0.00
NeuroPace (NPCE) United States $0.235B 0.00
Delcath Systems (DCTH) United States $0.210B 0.00
Inogen (INGN) United States $0.208B 0.00
Atossa Genetics (ATOS) United States $0.197B 0.00
Alpha Tau Medical (DRTS) Israel $0.197B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.170B 0.00
Semler Scientific (SMLR) United States $0.163B 8.25
Accuray (ARAY) United States $0.162B 0.00
Spectral Diagnostics (EDTXF) Canada $0.108B 0.00
KORU Medical Systems (KRMD) United States $0.104B 0.00
Sensus Healthcare (SRTS) United States $0.097B 20.45
Yubo Biotech (YBGJ) China $0.095B 0.00
Neuronetics (STIM) United States $0.078B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Monogram Orthopaedics (MGRM) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.064B 0.00
Vicarious Surgical (RBOT) United States $0.062B 0.00
Envoy Medical (COCH) United States $0.061B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
DarioHealth (DRIO) United States $0.057B 0.00
SEP Acquisition (SEPA) United States $0.049B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Autonomix Medical (AMIX) United States $0.047B 0.00
LENSAR (LNSR) United States $0.047B 0.00
ReWalk Robotics (LFWD) Israel $0.044B 0.00
Precision Optics (POCI) United States $0.039B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Aspira Women's Health (AWH) United States $0.033B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.029B 0.00
Ekso Bionics Holdings (EKSO) United States $0.025B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
Biosig Technologies (BSGM) United States $0.018B 0.00
PAVmed (PAVM) United States $0.017B 0.00
NexGel (NXGL) United States $0.015B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.010B 0.00
Avinger (AVGR) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00